Macroamylasemia
Authors:
- 2 November 1967
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 277 (18) , 941-946
Abstract
THE clinical conditions generally considered when serum amylase is found to be elevated are those that either increase the amount of amylase entering the plasma or alter renal function and thereby impair urinary excretion of the enzyme.1 In 1964 Wilding, Cooke and Nicholson2 demonstrated that elevated amylolytic activity could also result from the formation of an amylase-globulin complex that was too large to be readily excreted by the kidneys. This communication is concerned with observations made in 3 patients with persistent hyperamylasemia of previously unexplained cause. In each of these patients the major portion of the serum amylase was shown . . .Keywords
This publication has 8 references indexed in Scilit:
- Differentiation of parotid and pancreatic amylase in human serumDigestive Diseases and Sciences, 1966
- A Saccharogenic Method for Estimating Electrophoretic and Chromatographic Distribution of Human Serum AmylaseClinical Chemistry, 1965
- Globulin-bound AmylaseAnnals of Internal Medicine, 1964
- Hyperamylasemia of Renal Origin in the Absence of AzotemiaGastroenterology, 1963
- The plasma amylaseThe American Journal of Medicine, 1959
- Misinterpretation of Elevated Blood Diastase Due to Impaired Renal ClearanceArchives of Surgery, 1956
- Renal Clearance of Amylase in ManJournal of Applied Physiology, 1956
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951